Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : AMRN: Amarin Corporation plc -- Ignore unavailable to you. Want to Upgrade?

To: kenhott who wrote (24)	5/24/2008 1:26:23 PM
From: Mike McFarland	Read Replies (1) \| Respond to of 49

22-May-2008 Amarin announces completion of the first tranche of $60 million private placement. Appoints Four New Directors to Board. 19-May-2008 Amarin announces financial results for first quarter 2008 19-May-2008 Amarin announces financial results for fourth quarter and full year 2007 14-May-2008 Amarin announces private placement for up to $60 million 3-Mar-2008 Amarin Secures Global Intellectual Property Rights for Lipid Programs 11-Feb-2008 Amarin regains compliance with Nasdaq Listing Requirements 4-Feb-2008 Amarin appoints Dr. William Mason as Lead Independent Director 18-Jan-2008 Amarin provides business update and announces implementation of Reverse Stock Split 10-Jan-2008 Amarin to commence Phase II Trial with AMR101 in Age Associated Memory Impairment 9-Jan-2008 Amarin announces successful outcome of Nasal Lorazepam Study amarincorp.com